Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
1998-08-13
2001-11-27
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S312000, C546S113000, C546S156000
Reexamination Certificate
active
06323213
ABSTRACT:
The present invention relates to novel optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives, processes for their preparation and antibacterial compositions comprising them.
Quinolinecarboxylic acids and their antibacterial action have already been disclosed. Thus, ofloxacin, norfloxacin, enrofloxacin and danofloxacin are active compounds from this class of substance which are widely used in veterinary medicine. However, their use is not always satisfactory.
The present invention relates to optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives, of the general formula (I)
in which
R
1
represents hydrogen, C
1
-C
4
-alkyl which is optionally substituted by hydroxyl, methoxy, amino, methylamino or dimethylamino, or (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl,
R
2
represents hydrogen, benzyl, C
1
-C
3
-alkyl, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl, radicals having the structures —CH═CH—COOR
3
, —CH
2
CH
2
COOR
3
, —CH
2
CH
2
CN, —CH
2
CH
2
COCH
3
or —CH
2
COCH
3
, in which R
3
represents methyl or ethyl, or a radical of the general structure R
4
—(NH—CHR
5
—CO)
n
—, in which R
4
represents hydrogen, C
1
-C
3
-alkyl or the radical —COO-tert-butyl, R
5
represents hydrogen, C
1
-C
4
-alkyl, hydroxyalkyl, aminoalkyl, thioalkyl, carboxyalkyl or benzyl and n is 1 or 2, and
Y is oxygen or sulfur.
The compounds of the formula (I) can be present in the form of racemates or as enantiomerically pure compounds, and in the form of their pharmaceutically usable hydrates and acid addition salts, as well as in the form of their alkali metal, alkaline earth metal, silver and guanidinium salts.
The present invention relates to the process for the preparation of optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids, which is characterized in that compounds of the formula (II)
in which
R
1
and Y have the abovementioned meaning and
X represents halogen, in particular fluorine or chlorine,
are reacted with 2,8-diazabicyclo[4.3.0]nonanes of the formula (III)
in which
R
2
has the abovementioned meaning,
if appropriate in the presence of acid-binding agents. If appropriate, the carboxylic acid ester is then cleaved. If appropriate, compounds of the formula (I) in which R
2
represents hydrogen are then N-alkylated, N-alkenylated or N-acylated.
Compared with known representatives of this structural type, the compounds according to the invention have a more potent antibacterial action, in particular against
E. coli
, Staphylococci, Streptococci, Salmonellae and Mycoplasma. They are therefore suitable as active compounds for human and veterinary medicine. Their rapid degradation in the soil after excretion by the treated organism is advantageous.
Preferred compounds of the formula (I) are those in which
R
1
represents hydrogen, C
1
-C
4
-alkyl which is optionally substituted by hydroxyl, methoxy, amino, methyl amino or dimethylamino, or (5-methyl-2-oxo-1,3-dioxol4-yl)methyl,
R
2
represents hydrogen, benzyl, C
1
-C
3
-alkyl, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl, radicals of the structures —CH═CH—COOR
3
, —CH
2
CH
2
COOR
3
, —CH
2
CH
2
CN or —CH
2
COCH
3
, in which R
3
represents methyl or ethyl, or a radical of the general structure R
4
—(NH—CHR
5
—CO)
n
—, in which R
4
represents hydrogen, C
1
-C
3
-alkyl or the radical —COO-tert-butyl, R
5
represents hydrogen, C
1
-C
4
-alkyl, hydroxyalkyl, aminoalkyl, thioalkyl or benzyl and n is 1 or 2, and
Y represents oxygen,
and pharmaceutically usable hydrates and acid addition salts thereof, as well as the alkali metal, alkaline earth metal, silver and guanidinium salts of the carboxylic acids on which the compounds are based.
Particularly preferred compounds of the formula (I) are those in which
R
1
represents hydrogen, C
1
-C
4
-alkyl or (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl,
R
2
represents hydrogen, methyl, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl, radicals of the structures —CH═CH—COOR
3
, —CH
2
CH
2
COOR
3
, —CH
2
CH
2
CN or —CH
2
COCH
3
, in which R
3
represents methyl or ethyl, or a radical of the general structure R
4
—(NH—CHR
5
—CO)
n
—, in which R
4
represents hydrogen, C
1
-C
3
-alkyl or the radical —COO-tert-butyl, R
5
represents hydrogen, C
1
-C
4
-alkyl, hydroxyalkyl, aminoalkyl, thioalkyl or benzyl and n is 1 or 2, and
Y represents oxygen,
and pharmaceutically usable hydrates and acid addition salts thereof, as well as the alkali metal, alkaline earth metal, silver and guanidinium salts of the carboxylic acids on which the compounds are based.
If, for example, 7-chloro-8-cyano-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and 2,8-diazabicyclo[4.3.0]nonane are used for the preparation of compounds of the formula (I), the course of the reaction can be represented by the following equation:
Compounds of the formula (I) can also be obtained by a procedure in which, after the reaction of a compound of the formula (II) with 2,8-diazabicyclo[4.3.0]nonane, a further reaction of the resulting product is carried out. Thus, compounds of the formula (I) where R
2
is a radical —CH═CH═COOEt, for example, can be obtained in accordance with the following equation:
Compounds of the formula (I) in which R
1
represents hydrogen can be N-alkylated, N-alkenylated or N-acylated in a manner known per se.
For the N-alkylation, the alkyl halides or hydroxides corresponding to the radical R
2
or the alkenyls corresponding to the radical R
2
are used.
For the N-alkenylation, the alkinyls corresponding to the radical R
2
are used.
For the N-acylation, the acyl halides, in particular chlorides, or anhydrides corresponding to the radical R
2
are used.
Alkyl halides which may be mentioned are: benzyl chloride, C
1-3
-alkyl iodides, bromides or chlorides, methyl or ethyl chloroethanecarboxylate and chloroacetone;
alkenyls or alkinyls which may be mentioned are: methyl or ethyl propinyl-carboxylate, ethyl acrylate and acrylonitrile; and
acyl halides or anhydrides which may be mentioned are: acetyl chloride, pivaloyl chloride and N-tert-butyloxycarbonyl-L-alanine N-carboxyanhydride.
The N-alkylation with alkyl halides is preferably carried out in a diluent, such as, for example, dimethyl sulfoxide, N,N-dimethylformamide, sulfolane or acetonitrile.
Acid-binding agents which can be used are the customary inorganic and organic acid-binding agents, such as, for example, alkali metal hydroxides, alkali metal carbonates or organic amines.
The reaction temperatures can be varied within a substantial range here. The re-action is in general carried out between 20 and 200° C., preferably between 50 and 150° C.
The N-alkylation with alkenyls corresponding to the radical R
2
and the N-alkenylation with alkinyls corresponding to the radical R
2
are preferably carried out in a diluent, such as, for example, dimethyl sulfoxide, N,N-dimethylformamide, N-methyl-pyrrolidone, glycol, methylglycol or diethylene glycol.
The reaction temperatures can be varied here in a substantial range. In general, the reaction is carried out between 20 and 200° C., preferably between 50 and 180° C.
The N-acylation with acylhalides or anhydrides corresponding to the radical R
2
is preferably carried out in a diluent, such as, for example, dimethylsulfoxide, N,N-dimethylformamide, sulfolane or N-methylpyrrolidone.
The reaction can be carried out without an acid-binding agent or also in the presence of such an agent.
Acid-binding agents which can be employed are the customary inorganic and organic acid-binding agents, such as, for example, triethylamine, 1,4-diazabicyclo[2.2.2]octane and diazabicyclo[5.4.0]undec-7-ene.
The reaction temperatures can be varied within a substantial range here. In general, the reaction is carried out between −20° C. and 200° C., preferably betw
Bartel Stefan
Hallenbach Werner
Heinen Ernst
Himmler Thomas
Jaetsch Thomas
Akorli Godfried R.
Bayer Aktiengesellschaft
Gil Joseph C.
Kifle Bruck
LandOfFree
Possibly substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Possibly substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Possibly substituted... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2583280